← 返回

结肠肿瘤转移的空间蛋白质组学特征鉴定:一种数字空间谱分析方法

英文原题:Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis: A Digital Spatial Profiling Approach.

查看英文原题

Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis: A Digital Spatial Profiling Approach.

PubMed 2023/04/08(内容时间) Am J Pathol Q1 · IF 4.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

每年有超过150,000名美国人被诊断为结直肠癌(CRC),估计每年有超过50,000人死于CRC,因此需要改进筛查、预后评估、疾病管理和治疗选择。CRC肿瘤连同周围血管和淋巴管被整块切除。手术切除时检查区域淋巴结对于预后评估至关重要。开发间接评估复发风险的替代方法,在淋巴结检出数量不完整或不充分的情况下将具有实用价值。肿瘤内部及周围的空间依赖性、免疫细胞特异性(例如TIL(肿瘤浸润淋巴细胞)、蛋白质组学和转录组学表达模式——即肿瘤免疫微环境——可以预测淋巴结/远处转移,并探究原发肿瘤部位的协调免疫反应。使用高度多重空间组学技术,如GeoMX Digital Spatial Profiler,可以对TIL(肿瘤浸润淋巴细胞)和其他免疫浸润进行全面的表征。

在本研究中,机器学习和差异共表达分析有助于从Digital Spatial Profiler检测的肿瘤内部、侵袭边缘和远离肿瘤区域的蛋白质表达模式中识别生物标志物,这些标志物与细胞外基质重塑(例如颗粒酶B和纤连蛋白)、免疫抑制(例如叉头框P3)、耗竭和细胞毒性(例如CD8)、表达程序性死亡配体1的树突状细胞以及中性粒细胞增殖等相关变化有关。对这些生物标志物的进一步研究可能揭示CRC转移的独立风险因素,从而可以制定成低成本、广泛可用的检测方法。

展开英文摘要原文

Over 150,000 Americans are diagnosed with colorectal cancer (CRC) every year, and annually >50,000 individuals are estimated to die of CRC, necessitating improvements in screening, prognostication, disease management, and therapeutic options. CRC tumors are removed en bloc with surrounding vasculature and lymphatics. Examination of regional lymph nodes at the time of surgical resection is essential for prognostication. Developing alternative approaches to indirectly assess recurrence risk would have utility in cases where lymph node yield is incomplete or inadequate. Spatially dependent, immune cell-specific (eg, tumor-infiltrating lymphocytes), proteomic, and transcriptomic expression patterns inside and around the tumor-the tumor immune microenvironment-can predict nodal/distant metastasis and probe the coordinated immune response from the primary tumor site.

The comprehensive characterization of tumor-infiltrating lymphocytes and other immune infiltrates is possible using highly multiplexed spatial omics technologies, such as the GeoMX Digital Spatial Profiler.

In this study, machine learning and differential co-expression analyses helped identify biomarkers from Digital Spatial Profiler-assayed protein expression patterns inside, at the invasive margin, and away from the tumor, associated with extracellular matrix remodeling (eg, granzyme B and fibronectin), immune suppression (eg, forkhead box P3), exhaustion and cytotoxicity (eg, CD8), Programmed death ligand 1-expressing dendritic cells, and neutrophil proliferation, among other concomitant alterations.

Further investigation of these biomarkers may reveal independent risk factors of CRC metastasis that can be formulated into low-cost, widely available assays.

论文信息

作者
Levy JJ、Zavras JP、Veziroglu EM、Nasir-Moin M、Kolling FW、Christensen BC、Salas LA、Barney RE
第一作者单位
Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Health, Lebanon, New Hampshire; Department of Dermatology, Dartmouth Health, Lebanon, New Hampshire; Department of Epidemiology, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire; Program in Quantitative Biomedical Sciences, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire. Electronic address: joshua.j.levy@dartmouth.edu.Lebanon
通讯作者单位
Emerging Diagnostic and Investigative Technologies, Department of Pathology and Laboratory Medicine, Dartmouth Health, Lebanon, New Hampshire. Electronic address: gregory.j.tsongalis@hitchcock.org.Lebanon
文献类型
非美国政府资助研究 · 美国 NIH 资助研究
期刊
The American journal of pathology2023 Jun
原文标识
PubMed 37037284 · DOI 10.1016/j.ajpath.2023.02.020